QIM
IONS icon

Quest Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quest Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,705
Closed -$455K – 159
2014
Q3 		$455K Hold
11,705
– – 0.05% 130
2014
Q2 		$403K Buy
11,705
+1,395
+14% +$43.9K 0.04% 153
2014
Q1 		$445K Sell
10,310
-395
-4% -$19.1K 0.04% 145
2013
Q4 		$426K Sell
10,705
-5
-0% -$178 0.04% 151
2013
Q3 		$402K Sell
10,710
-1,365
-11% -$40.8K 0.03% 147
2013
Q2 		$324K Buy
+12,075
New +$257K 0.02% 154

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quest Investment Management's IONS Position: Q4 2014 in Review

Quest Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2014, closing a stake of 11,705 shares — an estimated $455K sold.

Quest Investment Management first reported a position in IONS in Q2 2013 and held it in 6 quarters. The position peaked at $455K in Q3 2014. 285 funds tracked by Wall St. Rank hold IONS as of Q4 2014.

  • Quest Investment Management reported no remaining Ionis Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Quest Investment Management sold 11,705 Ionis Pharmaceuticals shares in Q4 2014, an estimated $455K.
  • Quest Investment Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Quest Investment Management's Ionis Pharmaceuticals position peaked at $455K in Q3 2014.
  • 285 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2014.

Based on Quest Investment Management's 13F filing for Q4 2014, filed 12 Feb 2015.